NASDAQ: XTLB       Xtl Biopharma Ads
Last Price Today's Change   Day's Range   Trading Volume
1.31   0.00 (0.00%)  1.31 - 1.45  304


Avg Volume (4 weeks):3,096
4 Weeks Range:1.12 - 1.45
4 Weeks Price Volatility (%):
52 Weeks Range:0.625 - 2.33
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

XTL Biopharmaceuticals Ltd is engaged in the field of healthcare. It is a pharmaceutical manufacturer, with a focus on acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4064  1677  297  2912 

Top 10 Active Counters
 CETX 2.92+1.973 
 VISL 0.378+0.084 
 DGLY 2.34+1.22 
 AVP 5.60-0.05 
 AESE 4.69+2.24 
 PFE 35.47-2.72 
 AABA 19.630.00 
 NCLH 17.05+1.39 
 GE 6.699+0.128 
 OCGN 0.242-0.068 
Partners & Brokers